Cargando…
Blood Levels of Endocannabinoids, Oxylipins, and Metabolites Are Altered in Hemodialysis Patients
Hemodialysis patients (HDPs) have higher blood pressure, higher levels of inflammation, a higher risk of cardiovascular disease, and unusually low plasma n-3 polyunsaturated fatty acid (PUFA) levels compared to healthy subjects. The objective of our investigation was to examine the levels of endocan...
Autores principales: | Watkins, Bruce A., Friedman, Allon N., Kim, Jeffrey, Borkowski, Kamil, Kaiser, Shaun, Fiehn, Oliver, Newman, John W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456435/ https://www.ncbi.nlm.nih.gov/pubmed/36077177 http://dx.doi.org/10.3390/ijms23179781 |
Ejemplares similares
-
Tai Chi exercise reduces circulating levels of inflammatory oxylipins in postmenopausal women with knee osteoarthritis: results from a pilot study
por: Shen, Chwan-Li, et al.
Publicado: (2023) -
Effects of hemodialysis on plasma oxylipins
por: Gollasch, Benjamin, et al.
Publicado: (2020) -
Plasma Oxylipin Profile Discriminates Ethnicities in Subjects with Non-Alcoholic Steatohepatitis: An Exploratory Analysis
por: Mazi, Tagreed A., et al.
Publicado: (2022) -
Type 2 Diabetes Associated Changes in the Plasma Non-Esterified Fatty Acids, Oxylipins and Endocannabinoids
por: Grapov, Dmitry, et al.
Publicado: (2012) -
Genome-wide analysis of oxylipins and oxylipin profiles in a pediatric population
por: Buckner, Teresa, et al.
Publicado: (2023)